Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study D Nepogodiev, A Bhangu, JC Glasbey, E Li, OM Omar, JFF Simoes, ... The Lancet 396 (10243), 27-38, 2020 | 1897 | 2020 |
Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer MM Yallapu, S Khan, DM Maher, MC Ebeling, V Sundram, N Chauhan, ... Biomaterials 35 (30), 8635-8648, 2014 | 309 | 2014 |
Curcumin nanoformulation for cervical cancer treatment MS Zaman, N Chauhan, MM Yallapu, RK Gara, DM Maher, S Kumari, ... Scientific reports 6 (1), 20051, 2016 | 212 | 2016 |
Non-Hodgkin’s lymphomas, version 4.2014 AD Zelenetz, LI Gordon, WG Wierda, JS Abramson, RH Advani, ... Journal of the National Comprehensive Cancer Network 12 (9), 1282-1303, 2014 | 185 | 2014 |
Machine learning based decision support systems (DSS) for heart disease diagnosis: a review S Safdar, S Zafar, N Zafar, NF Khan Artificial Intelligence Review 50 (4), 597-623, 2018 | 181 | 2018 |
NCCN guidelines insights: non-Hodgkin's lymphomas, version 3.2016 SM Horwitz, AD Zelenetz, LI Gordon, WG Wierda, JS Abramson, ... Journal of the National Comprehensive Cancer Network 14 (9), 1067-1079, 2016 | 164 | 2016 |
PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer PKB Nagesh, NR Johnson, VKN Boya, P Chowdhury, SF Othman, ... Colloids and Surfaces B: Biointerfaces 144, 8-20, 2016 | 136 | 2016 |
Non-Hodgkin's lymphomas AD Zelenetz, JS Abramson, RH Advani, CB Andreadis, N Bartlett, ... Journal of the National Comprehensive Cancer Network 9 (5), 484-560, 2011 | 130 | 2011 |
Smoking and COVID-19: adding fuel to the flame VK Kashyap, A Dhasmana, A Massey, S Kotnala, N Zafar, M Jaggi, ... International journal of molecular sciences 21 (18), 6581, 2020 | 124 | 2020 |
MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer S Khan, MC Ebeling, MS Zaman, M Sikander, MM Yallapu, N Chauhan, ... Oncotarget 5 (17), 7599, 2014 | 120 | 2014 |
Diffuse large B-cell lymphoma version 1.2016 AD Zelenetz, LI Gordon, WG Wierda, JS Abramson, RH Advani, ... Journal of the National Comprehensive Cancer Network 14 (2), 196-231, 2016 | 98 | 2016 |
Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015 AD Zelenetz, LI Gordon, WG Wierda, JS Abramson, RH Advani, ... Journal of the National Comprehensive Cancer Network 13 (3), 326-362, 2015 | 88 | 2015 |
Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer S Khan, MC Ebeling, N Chauhan, PA Thompson, RK Gara, A Ganju, ... Cancer research 75 (11), 2292-2304, 2015 | 82 | 2015 |
Non-Hodgkin’s lymphomas, version 1.2013 AD Zelenetz, WG Wierda, JS Abramson, RH Advani, CB Andreadis, ... Journal of the National Comprehensive Cancer Network 11 (3), 257-273, 2013 | 81 | 2013 |
Ormeloxifene suppresses prostate tumor growth and metastatic phenotypes via inhibition of oncogenic β-catenin signaling and EMT progression BB Hafeez, A Ganju, M Sikander, VK Kashyap, ZB Hafeez, N Chauhan, ... Molecular cancer therapeutics 16 (10), 2267-2280, 2017 | 59 | 2017 |
Mediastinal needle biopsy. A 15‐year experience with 139 cases N Zafar, S Moinuddin Cancer 76 (6), 1065-1068, 1995 | 57 | 1995 |
Non-Hodgkin’s lymphomas, version 2.2014 AD Zelenetz, LI Gordon, WG Wierda, JS Abramson, RH Advani, ... Journal of the National Comprehensive Cancer Network 12 (6), 916-946, 2014 | 52 | 2014 |
Nanoparticle formulation of ormeloxifene for pancreatic cancer S Khan, N Chauhan, MM Yallapu, MC Ebeling, S Balakrishna, RT Ellis, ... Biomaterials 53, 731-743, 2015 | 51 | 2015 |
Atypical squamous cells, cannot exclude a high‐grade intraepithelial lesion and its clinical significance in postmenopausal, pregnant, postpartum, and contraceptive‐use patients AL Patton, L Duncan, L Bloom, G Phaneuf, N Zafar Cancer Cytopathology: Interdisciplinary International Journal of the …, 2008 | 50 | 2008 |
Non-Hodgkin’s lymphomas, version 3.2012 AD Zelenetz, WG Wierda, JS Abramson, RH Advani, CB Andreadis, ... Journal of the National Comprehensive Cancer Network 10 (12), 1487-1498, 2012 | 47 | 2012 |